Low production in January, February led to shortage of Remdesivir | Hyderabad News
It’s not just the sudden spike in Covid-19 cases that has resulted in an acute shortage of anti-viral drug Remdesivir. One of the key reasons behind t
Stay updated with breaking news from Biocon Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
It’s not just the sudden spike in Covid-19 cases that has resulted in an acute shortage of anti-viral drug Remdesivir. One of the key reasons behind t
ValGenesis Collaborates with Biocon Biologics for Digital Validation Across Multiple Sites News provided by Share this article Share this article SAN FRANCISCO, Dec. 15, 2020 /PRNewswire/ -- ValGenesis Inc., a market leader in Enterprise Validation Lifecycle Management Solutions (VLMS), today announced that the Equipment Commissioning and Qualification (C&Q) process (validation life cycle) at Biocon Biologics has been digitized leveraging the power of ValGenesis VLMS – the industry's most trusted electronic validation lifecycle management system. Biocon Biologics, a subsidiary of Biocon, i...